Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
8.20
+0.05 (0.61%)
Oct 13, 2025, 4:00 PM EDT - Market closed

Terns Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
718471401504179-
Upgrade
Market Cap Growth
-8.12%17.33%-20.44%182.18%--
Upgrade
Enterprise Value
403991353181-
Upgrade
Last Close Price
8.205.546.4910.187.07-
Upgrade
PS Ratio
----178.64-
Upgrade
PB Ratio
2.351.361.571.821.11-
Upgrade
P/TBV Ratio
2.351.361.571.821.11-
Upgrade
EV/Sales Ratio
----1.44-
Upgrade
Debt / Equity Ratio
0.000.000.000.00-0.19
Upgrade
Asset Turnover
----0.01-
Upgrade
Quick Ratio
24.4322.8922.0633.4324.343.28
Upgrade
Current Ratio
24.7023.1422.3933.6824.483.98
Upgrade
Return on Equity (ROE)
-35.02%-29.56%-33.89%-27.60%-43.83%-68.73%
Upgrade
Return on Assets (ROA)
-23.97%-20.13%-23.08%-17.04%-23.94%-39.83%
Upgrade
Return on Capital (ROIC)
-25.15%-21.11%-24.00%-17.68%-25.78%-46.38%
Upgrade
Earnings Yield
-12.79%-18.88%-22.49%-11.97%-28.08%-
Upgrade
FCF Yield
-10.36%-14.89%-16.82%-9.80%-23.61%-
Upgrade
Buyback Yield / Dilution
-20.32%-11.58%-97.76%-58.69%-7862.47%-55.60%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q